Touchlight secures $2.4m to prove pandemic potential of synthetic DNA vector

Retrieved on: 2022-11-29 22:01:18

Tags for this article:

Click the tags to see associated articles and topics

Touchlight secures $2.4m to prove pandemic potential of synthetic DNA vector. View article details on hiswai:

Excerpt

... performance of dbDNA for therapeutic monoclonal antibody production. ... produce therapeutic relevant levels of monoclonal antibodies in vivo.

Article found on: www.biopharma-reporter.com